ONO-AE 248
ONO-AE 248 is a selective EP3 receptor agonist with cardioprotective activity. ONO-AE 248 reduces myocardial infarction size by selectively binding to the EP3α receptor in mice. The cardioprotective effect of ONO-AE 248 is independent of hemodynamic effects. The mechanism of ONO-AE 248 may involve activation of protein kinase C and opening of K (ATP) channels[1].
Product Specifications
CAS Number
211230-67-0
UNSPSC
12352211
Target
Endogenous Metabolite; Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ono-ae-248.html
Purity
98.27
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CCCCC[C@H](OC)/C=C/[C@@H]1[C@H](C(C[C@H]1OC)=O)C/C=C\CCCC(O)=O
Molecular Formula
C22H36O5
Molecular Weight
380.52
References & Citations
[1]Selective activation of the prostanoid EP (3) receptor reduces myocardial infarct size in rodents
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GATA4 (GATA Binding Factor 4, ASD2, VSD1) (HRP)
GATA4 (GATA Binding Factor 4, ASD2, VSD1) (HRP)
